Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Asia-Pacific Journal of Clinical Oncology|August 12, 2020
Long-term persistence of immune response to the AS04-adjuvanted HPV-16/18 vaccine in Chinese girls aged 9-17 years: Results from an 8-9-year follow-up phase III open-label studyYuemei Hu, Xiang Zhang, Yilin He, et al.
Human Vaccines & Immunotherapeutics|November 12, 2020
Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trialShangying Hu, Xiaoqian Xu, Fengcai Zhu, et al.
Human Vaccines & Immunotherapeutics|March 18, 2014
Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trialYi-Juan Chen, Fan-Yue Meng, Qunying Mao, et al.
Asia-Pacific Journal of Clinical Oncology|September 14, 2022
Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up studyFanghui Zhao, Archana Jastorff, Ying Hong, et al.
The New England Journal of Medicine|February 28, 2014
Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in ChinaFengcai Zhu, Wenbo Xu, Jielai Xia, et al.
The Lancet Regional Health. Western Pacific|September 16, 2021
Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort studyXingmei Yao, Wen Chen, Chao Zhao, et al.
The Lancet. Respiratory Medicine|June 1, 2022
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trialsFengcai Zhu, Chunlan Zhuang, Kai Chu, et al.
Pageof 5